Guardant360® Liquid - Extended Panel

4.8/5
Guardant360 Liquid is the most comprehensive liquid biopsy we offer for advanced solid cancer: a single blood test analysing more than 740 cancer genes together with over 19,000 epigenomic signals, detecting variants at levels as low as 0.001 percent, to find treatment options that smaller panels miss. From £4,320, following a consultation with our consultant oncologist to confirm it is right for you. Results in 7 working days, oncologist reviewed.... Read more

Guardant360 Liquid is the most comprehensive liquid biopsy we offer for advanced solid cancer: a single blood test analysing more than 740 cancer genes together with over 19,000 epigenomic signals, detecting variants at levels as low as 0.001 percent, to find treatment options that smaller panels miss. From £4,320, following a consultation with our consultant oncologist to confirm it is right for you. Results in 7 working days, oncologist reviewed.

Key facts

  • Price: from £4,320 with your own sample collection; £4,349 at a Goodbody clinic; £4,380 with a nurse home visit. A 30-minute oncologist consultation (£149) is required first and is refunded against the test if you go ahead
  • Analyses: 740+ genes for mutations, fusions and amplifications, plus 19,000+ epigenomic (methylation) signals, from circulating tumour DNA
  • Sensitivity: detects variants down to 0.001 percent mutant allele fraction
  • For: adults with advanced solid cancer (stage III or IV) whose cancer has progressed on treatment, whose tissue testing was inconclusive, or whose oncologist wants the broadest possible search for options; off treatment for at least 10 days
  • Not for: blood cancers or early-stage cancers; not a screening test
  • Results: within 7 working days of the sample reaching the laboratory, reviewed with you by our consultant oncologist
  • Brochures: Information sheet and gene panel specification (PDF)

Your questions answered

What is Guardant360 Liquid, and how is it different from Guardant360 CDx?

Both are liquid biopsies that profile tumour DNA from a blood sample to guide treatment of advanced solid cancer. Guardant360 CDx sequences 74 genes, the ones with approved targeted therapies, and is the established, FDA-approved panel. Guardant360 Liquid, built on the GuardantINFINITY platform, sequences more than 740 genes and adds more than 19,000 epigenomic signals, so it can find rarer alterations, resistance mechanisms and trial-eligible targets that a 74-gene panel does not cover, and it detects variants at lower levels. Our oncologist advises which is the right test for your situation; for many people CDx is sufficient, and Liquid is chosen when the search needs to be as broad as possible.

Who is the extended panel for?

People with a confirmed advanced solid cancer where a broader search could change treatment: when CDx or tissue testing found nothing actionable, when the cancer has progressed on a targeted therapy and the resistance mechanism matters, when a clinical trial is being considered, or when a rare cancer type makes a wide panel more informative. As with CDx, you need to be at least 10 days off treatment. It is not for blood cancers, early-stage disease or screening.

What do the epigenomic signals add?

Genomic sequencing finds changes in the DNA code. Epigenomic analysis looks at methylation, chemical marks that switch genes on and off, which cancers alter extensively. Including 19,000 methylation signals improves the detection of tumour DNA when little is present, helps distinguish tumour DNA from age-related changes in normal blood cells, and can reveal how a cancer has adapted to treatment. It is the reason this panel is described as multi-dimensional rather than simply larger.

What does 0.001 percent sensitivity mean in practice?

Circulating tumour DNA is a tiny fraction of the DNA in blood; the rest comes from normal cells. Detecting a variant at 0.001 percent mutant allele fraction means the test can find one tumour-derived fragment among 100,000 normal ones. That matters when the tumour sheds little DNA, for example after partial response to treatment, where a less sensitive test might report nothing.

Why is an oncologist consultation required first?

To make sure the test can change something. Our consultant oncologist reviews your diagnosis, stage, previous genomic results and treatment history, confirms you have been off treatment long enough, and advises whether Guardant360 Liquid or the smaller CDx panel is the better choice. The consultation is a 30-minute telephone call, costs £149, is refunded if you proceed, and does not replace your own oncologist.

How much does the Guardant360 Liquid test cost?

From £4,320 with your own blood collection, £4,349 at a Goodbody clinic or £4,380 with a nurse home visit, including sequencing, epigenomic analysis, the clinical report and a results consultation with our oncologist. The £149 consultation is refunded against the test. The 74-gene Guardant360 CDx is from £2,469.

What does the report show?

The genomic alterations found, mutations, fusions, amplifications and biomarkers such as tumour mutational burden and microsatellite instability, matched to approved therapies and clinical trials for your cancer type, plus epigenomic findings and the tumour DNA fraction, which indicates how much weight a negative finding carries. Guardant updates the panel's features over time at no extra cost. Our oncologist walks you through the report and writes a summary for your treating team.

How long does the process take?

The oncologist consultation is usually available within days. Results are returned within 7 working days of the sample reaching the laboratory, and your results consultation is booked as soon as the report arrives. Most people have a report in hand within two to three weeks of first contact.

Is this available on the NHS?

Not as a 740-gene panel. The NHS Genomic Medicine Service offers smaller targeted panels for specific cancers, and Guardant360 CDx for some lung cancer patients. Private testing is the route to the extended panel in the UK.

Can this test tell me if I have cancer?

No. It is a treatment-guidance test for people with a confirmed diagnosis of advanced solid cancer, not a screening test. For screening without a diagnosis, see our TruCheck test.

Where can I have the blood taken?

At any of 250+ Goodbody clinics across the UK, by a nurse at home, or by a professional you arrange using the kit we send you. No fasting is needed. Find your nearest clinic.

What happens next

Your results are emailed within the stated turnaround of your sample reaching the laboratory, and are reviewed with you by our consultant oncologist, who explains what the findings mean and sets out the options to discuss with your treating team. Your report is written for oncologists and can be shared with your own specialist. All samples are analysed by an accredited laboratory.

Read less
  • Venous Sample
  • Oncologist Supported
  • Therapy Guidance
  • 250+ Clinic Locations
  • Results in 7 Working Days
Check Availability (Based on location)
  • Clearpay
  • Splitit
  • Visa
  • Mastercard
  • Apple Pay
  • Shop Pay
  • Google Pay
More Information

The test can be performed as advised by the Oncologist, without the cost and risks involved with radiation from scans, hospitalisation, anaesthesia or painful surgical biopsies.

Benefits:

  • Get peace of mind & monitor your solid cancer diagnosis
  • Make informed treatment decisions for patients who have progressed on therapy
  • No waiting lists
  • Consultation with Oncologist to advise on the test (not to take on your primary oncologist care).

 

Who can take the Guardant360 Liquid blood test?

Individuals who have been diagnosed with advanced solid cancer (stage III/IV) whereby the cancer is not progressing on the current treatment or current tumour testing is incomplete or inconclusive.

Patient must have been off treatment for a minimum of 10 days.

Not suitable for individuals with:

  • Hematologic malignancies (Blood / lymph nodes / bone)
  • Early stage (stage I/II) cancers

 

How does the process work?

  1. Book and pay for a consultation with our Oncologist to ensure suitability and determine this test is right for you.
  2. If suitable, book your Guardant360 Liquid test – in clinic or at home with a nurse visit.
  3. Attend your appointment.
  4. Receive your results within 7 working days of the sample reaching the lab.

 

How does the Guardant360 Liquid test work?

Guardant360 Liquid is a simple blood test which analyses 740+ genes within your existing solid cancer tumour DNA and 19,000+ epigenetic signals, to provide cancer genomic alterations detected in your blood.

Some genomic alterations may mean you are more likely to respond to certain drugs, or, indicate your cancer could be resistant to treatment. An oncologist will interpret results to inform the best treatment for you.

The report will highlight current approved drugs available and drugs currently available on clinical trial.

Traditionally, the only way to analyse genomic changes in your cancer was through tissue biopsies. The Guardant360 Liquid test can provide the same information from a simple blood draw.

How often should I test?

Testing frequency depends on your condition – the Oncologist will advise a test schedule that works best for you.

When will I get my results?

The results are typically returned to you via email within 7 working days of reaching the lab.

Not sure if this test
is right for you?

Enquire via the form and a member of our team will get back to you, they are more than happy to help answer your questions and talk through the best option for you.

Contact us if you aren't sure, we'd be happy to help!

Register Your Interest

FAQs

PLACING AN ORDER

How does the service work?

Who will take my blood draw?

Who sends off my sample?

How do I book?

Can I book the blood draw for someone else?

Can I eat or drink before my blood draw?

My sample needs centrifuging

We promise to deliver affordable testing to everybody.

When you’re worried about your health, life can feel very stressful, especially if you don’t have the answers you need. We believe that health testing should be available to all, giving you answers when and where you need them.

That’s why we’ve partnered with Splitit, Dopple and Clearpay so you can pay for your tests in interest-free instalments, if you prefer.